CD79A and myeloid sarcoma: This implies that IgA-binding affinity could be fundamentally compromised in MS, perhaps through B-cell dysfunction, posttranslational modifications that reduce antibody polyreactivity, deglycosylation of secretory immunoglobulin A by Akkermansia muciniphila, or other factors that inhibit polyreactive antibody binding.43,44